Current Issue | New England Journal of Medicine
Nov 27, 2025 · Explore the current issue of The New England Journal of Medicine (Vol. 393 No. 21).
The New England Journal of Medicine | Research & Review Articles …
The New England Journal of Medicine (NEJM) is a weekly general medical journal that publishes new medical research and review articles, and editorial opinion on a wide variety of topics of ...
About NEJM - The New England Journal of Medicine
The New England Journal of Medicine (NEJM) is recognized as the world’s leading medical journal and website. Published continuously for over 200 years, NEJM delivers high-quality, …
Issue Index | New England Journal of Medicine
Index of all Issues from New England Journal of Medicine
Recently Published - The New England Journal of Medicine
Nov 29, 2025 · Explore this issue of The New England Journal of Medicine (Vol. 0 No. 0).
Clinical Practice Topics | The New England Journal of Medicine
A Accountable Care Organizations Acute Coronary Syndromes Acute Kidney Injury Addiction Adolescent Medicine Adrenal Disease AI in Medicine Allergy Allergy/Immunology General …
Daratumumab or Active Monitoring for High-Risk Smoldering …
Dec 9, 2024 · Daratumumab, an anti-CD38 monoclonal antibody, has been approved for the treatment of multiple myeloma. Data are needed regarding the use of daratumumab for high …
Medical Articles | The New England Journal of Medicine
Explore the index of articles published by the New England Journal of Medicine, from original research to videos in clinical medicine and more.
Medical Specialties | The New England Journal of Medicine
Featuring articles on topics such as leukemia, breast cancer, colon cancer, mammograms, colonoscopy, occult-blood screening, stem cell and bone marrow transplantation, radiation, …
Perioperative Durvalumab with Neoadjuvant Chemotherapy in …
Sep 15, 2024 · Neoadjuvant chemotherapy followed by radical cystectomy is the standard treatment for cisplatin-eligible patients with muscle-invasive bladder cancer. Adding …